Advertisement

Topics

Canaan Partners Company Profile

04:03 EDT 17th October 2017 | BioPortfolio

Partners for the Long Term We invest more than money in a company. We invest our time, experience, knowledge, connections and team-oriented approach. We place tremendous value on creating working partnerships with entrepreneurs and management teams who have the drive to succeed

Location

2765 Sand Hill Road
Menlo Park
California
94025
United States of America

Contact

Phone: 650) 854-8092
Fax: 650) 854-8127
Email: kchou@canaan.com


News Articles [105 Associated News Articles listed on BioPortfolio]

Finance Watch: Canaan Closes New VC Fund; CARB-X Backs More Antibiotics

Canaan raised $800m for tech and health care investments. Also, six companies closed VC rounds, CARB-X backed more antibiotics, CIRM...    

#news #biotech Canaan unveils $800M fund for fresh wave of biotech bets

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Canaan unveils $800M fund for fresh wave of biotech bets .Canaan has put toge...

Cancer-Focused Vivace Emerges with $40M in Financing

A cancer-focused drug discoverer and developer emerged from stealth mode by disclosing today that it has raised $40 million in Series A and Series B financings. Vivace Therapeutics said that its $...

Truveris Raises $25M for Data-Driven Platform to Transform Prescription Benefits Ecosystem

Truveris, a provider of cloud-based data analytics solutions for the prescription benefits industry has raised $25 million in Series D funding led by McKesson Ventures, and included Canaan Partners, N...

Glooko Raises $35M to Expand Diabetes Data Platform Internationally

Glooko, a Mountain View, CA-based provider of diabetes data management has rasied $35 million in Series C funding led by Georgian Partners with participation from Insulet Corporation, Mayo Clinic, Can...

Takeda-Advinus R&D Alliance ‘Closed’

Takeda’s alliance with Advinus Therapeutics, a much-touted deal that had put the spotlight on the Indian R&D services firm, has...   

Canaan raises $800M fund

Vivace raises $25mm in Series B round

Vivace Therapeutics Inc. (oncology drug discovery) raised $25mm in its Series B round from new investors Cenova (lead) and Sequoia Capital, along with Mission Bay Capital and founding investors Canaan...

Drugs and Medications [21 Associated Drugs and Medications listed on BioPortfolio]

Sweatblock [DC Alpine Partners, LLC DBA: Sweatblock]

SWEATBLOCK Clinical Strength Antiperspirant

Day cream mattifying hydrator [MOSAIC MARKETING PARTNERS LLC]

DAY CREAM MATTIFYING HYDRATOR

Ribavirin [Sandoz Inc]

These highlights do not include all the information needed to use RIBAVIRIN TABLETS safely and effectively. See full prescribing information for RIBAVIRIN TABLETS. Ribavirin Tablets, oralInitial U.S. ...

Ribavirin [Cadila Healthcare Limited]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

Ribavirin [Zydus Pharmaceuticals (USA) Inc.]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

PubMed Articles [233 Associated PubMed Articles listed on BioPortfolio]

A qualitative study of secondary distribution of HIV self-test kits by female sex workers in Kenya.

Promoting awareness of serostatus and frequent HIV testing is especially important among high risk populations such as female sex workers (FSW) and their sexual partners. HIV self-testing is an approa...

Male engagement in women's microbicide use in Kenya: Navigating gender norms.

The success of women's microbicide use for HIV/AIDS prevention may hinge on health programs' ability to engage men to support it. In this qualitative study in Kenya, most women did not or would not te...

Psychological distress in men with prostate cancer and their partners before and after cancer diagnosis: a longitudinal study.

To examine the relative risk of psychological distress of men with prostate cancer and their partners during the period before and after prostate cancer diagnosis compared with men without prostate ca...

Partners of nulliparous women with severe fear of childbirth: A longitudinal study of psychological well-being.

Little is known about the psychological status of partners of women with severe fear of childbirth (FOC). In this longitudinal study from Helsinki University Central Hospital, we investigated FOC, dep...

A Qualitative Study of Means to Improve Partner Notification After an HIV Diagnosis Among Men Who Have Sex with Men in Australia.

Improved partner notification (PN) after HIV diagnosis could help control HIV among men who have sex with men (MSM). However, there is little evidence exploring what this experience is like for Austra...

Clinical Trials [239 Associated Clinical Trials listed on BioPortfolio]

Partners Demonstration Project of PrEP and ART

The purpose of this protocol is to determine user preferences for antiretroviral therapy (ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected partners an...

Teachers and Parents as Partners During Middle School

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Treatment for Men Who Are Abusive to Their Partners

This study will develop an individual behavior therapy for men who are violent toward their partners and will compare the therapy to standard group treatment.

Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners

This pilot clinical trial studies how well acceptance and commitment therapy works in improving well-being in patients with stage III-IV cancer and their partners. Learning how to accept n...

Communication and Intimacy-Enhancing Therapy for Men With Early Stage Prostate Cancer and Their Partners

RATIONALE: Participating in a therapy program may enhance communication and intimacy between men with prostate cancer and their partners. PURPOSE: This randomized clinical trial is studyi...

Companies [883 Associated Companies listed on BioPortfolio]

Canaan Partners

Partners for the Long Term We invest more than money in a company. We invest our time, experience, knowledge, connections and team-oriented approach. We place tremendous value on creating working part...

Marinus Pharmaceuticals, Inc.

Marinus is a specialty pharmaceutical company dedicated to the reformulation, development, and commercialization of novel drugs to treat serious neurological, psychiatric, and pain disorders. Marinus ...

Durata Therapeutics, Inc.

Durata Therapeutics is a biopharmaceutical company addressing the growing need for new antibiotics to treat infectious diseases. Durata’s lead product candidate, dalbavancin,...

Theraclone Sciences, Inc.

Theraclone Sciences is a Seattle‐based biotechnology company focused on the development of novel therapeutic antibodies for the treatment of infectious disease and cancer. Th...

Theraclone Sciences

Theraclone Sciences is a Seattle‐based biotechnology company focused on the development of novel therapeutic antibodies for the treatment of infectious disease and cancer. Th...

More Information about "Canaan Partners" on BioPortfolio

We have published hundreds of Canaan Partners news stories on BioPortfolio along with dozens of Canaan Partners Clinical Trials and PubMed Articles about Canaan Partners for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Canaan Partners Companies in our database. You can also find out about relevant Canaan Partners Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record